The All-Russia Research Team These outstanding analysts of the year are regarded as Russia's top equity and fixed-income researchers. June 13, 2011 Related Articles From Deep Losses to Remarkable Gains: Biopharma’s Wildest Year in Recent Memory Stephen Taub The Numbers Are in on Short Sellers’ Losing Year Michelle Celarier Podcast- Inverting Risk and Capturing the Spread: Merger Arbitrage Explained Sponsored by Fidelity Investments